merged_340b-apexus-drugs-middleman.txt
<question_number>1</question_number>
<answer>Apexus</answer>
<other>The article directly states Apexus was projected to reach $227 million in revenue with over 80% profit margins.</other>
<question_number>2</question_number>
<answer>Apexus</answer>
<other>Marsha Simon described Apexus as having "a license to hunt."</other>
<question_number>3</question_number>
<answer>Apexus</answer>
<other>The article explicitly mentions Apexus's purchasing optimization team and bonus structure.</other>
<question_number>4</question_number>
<answer>Virginia King</answer>
<other>The article details Virginia King's experience with the differing charges.</other>
<question_number>5</question_number>
<answer>340B Drug Pricing Program</answer>
<other>The article states the cost of the 340B program increased by over 200% in New York.</other>
<question_number>6</question_number>
<answer>Apexus</answer>
<other>The article states Apexus sells a $750 certification course and offers broad interpretations of eligibility rules.</other>
<question_number>7</question_number>
<answer>acting more like a sales-driven business</answer>
<other>The article states Pedley criticized Apexus for acting like a sales-driven business.</other>
<question_number>8</question_number>
<answer>North Carolina</answer>
<other>The article states North Carolina saw a 50% jump in prescription drug spending.</other>
<question_number>9</question_number>
<answer>Acentrus</answer>
<other>The article states Acentrus helped hospitals provide data to manufacturers.</other>
<question_number>10</question_number>
<answer>Apexus</answer>
<other>The article states Apexus charges a 3% fee for generic drugs and handles non-340B purchases.</other>